In an interview with Fierce Biotech Publisher Rebecca Willumson, SAP’s Kevin Brophy and Michael Greene of Answerthink explained how small and emerging biopharmaceutical companies can transition from ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果